Clinic
Oakes Family Care, LLC Dba the Doctor's Office: Oakes Family Care
Oakes Family Care, LLC Dba the Doctor's Office: Oakes Family Care was paid $1.09M by Medicaid between Jan 2018 and Nov 2021, across 69 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoOAKES FAMILY CARE, LLC DBA THE DOCTOR'S OFFICE: OAKES FAMILY CARE
GREENVILLE, MS 38703
GREENVILLE, MS 38703
33aNPI1669804910assigned 08/08/2013
33bProvider typePrimary Care Clinic/Center
28Total paid$1.09M
24GClaims86,810
24DCodes billed69
24AFirst – last monthJan 2018 – Nov 2021
Compared with peers
Next to other Primary Care Clinic/Center providers in Mississippi
Rank by total paid#12 of 85
Median peer was paid$100K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,847 | $236K | |
| 2019 | 31,996 | $465K | |
| 2020 | 18,103 | $228K | |
| 2021 | 15,864 | $164K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 13,768 | 8,396 | $424K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 15% | 5,462 | 4,220 | $167K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 4,595 | 3,326 | $144K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.4% | 1,542 | 1,041 | $81K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 10,447 | 7,163 | $41K |
| 80053 | Comprehensive metabolic panel | 3.0% | 6,608 | 5,107 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 4,542 | 2,410 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2.0% | 1,039 | 687 | $22K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 1,138 | 770 | $19K |
| 36415 | Collection of venous blood by venipuncture | 1.7% | 12,617 | 8,610 | $18K |
| 83013 | 1.4% | 464 | 335 | $15K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,068 | 853 | $10K |
57 more codes
| 80061 | Lipid panel | <1% | 1,673 | $9K |
| 82977 | <1% | 1,782 | $6K | |
| 99307 | <1% | 604 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,123 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,606 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 71 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 568 | $4K |
| 99442 | <1% | 240 | $4K | |
| 80305 | <1% | 567 | $4K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 257 | $4K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 190 | $3K |
| 83735 | <1% | 1,423 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 418 | $3K |
| 82607 | <1% | 594 | $3K | |
| 81025 | <1% | 521 | $3K | |
| 82550 | <1% | 984 | $2K | |
| 20610 | <1% | 161 | $2K | |
| 84100 | <1% | 1,315 | $2K | |
| 84403 | <1% | 206 | $2K | |
| 99490 | Ccm add 20min | <1% | 408 | $2K |
| 87634 | <1% | 41 | $2K | |
| 90674 | <1% | 379 | $2K | |
| 83014 | <1% | 456 | $2K | |
| 83037 | <1% | 1,209 | $2K | |
| 81003 | <1% | 1,383 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 17 | $836.40 |
| 92551 | <1% | 169 | $835.39 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,097 | $820.26 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 87 | $745.00 |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 61 | $711.42 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 208 | $623.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 68 | $585.62 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 672 | $553.00 |
| 81002 | <1% | 227 | $381.24 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,289 | $380.14 |
| 80050 | General health panel | <1% | 22 | $322.56 |
| 82044 | <1% | 159 | $314.16 | |
| 82043 | <1% | 68 | $305.60 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 52 | $288.52 |
| 99304 | <1% | 12 | $216.82 | |
| 90715 | <1% | 51 | $198.60 | |
| 87807 | <1% | 14 | $192.40 | |
| 99401 | <1% | 60 | $160.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $148.80 |
| 90756 | <1% | 15 | $133.30 | |
| 99173 | <1% | 124 | $120.07 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 208 | $95.49 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 18 | $95.16 |
| 96127 | <1% | 63 | $94.78 | |
| 96160 | <1% | 71 | $93.74 | |
| 90686 | <1% | 87 | $56.14 | |
| 84550 | <1% | 15 | $36.16 | |
| J1094 | Injection, dexamethasone acetate, 1 mg | <1% | 95 | $22.52 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 68 | $0.21 |
| 90651 | 0% | 38 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 130 | $0.00 |
| 90734 | 0% | 60 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOAKES, LUTHER (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Oakes Family Pain Solutions PLLC | Greenville, MS | $421K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.